Selected research
Industry Research
Human Single-Cell Multi-Omics Industry Research Report 2026
Market perspective
The global Human Single-Cell Multi-Omics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Human Single-Cell Multi-Omics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Human Single-Cell Multi-Omics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Human Single-Cell Multi-Omics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Human Single-Cell Multi-Omics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Human Single-Cell Multi-Omics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Single-Cell Multi-Omics Market by Company
10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio
Human Single-Cell Multi-Omics Segment by Type
Single-Cell Proteomics
Single-Cell Genomics
Single-Cell Transcriptomics
Human Single-Cell Multi-Omics Segment by Application
Synthetic Biology
Clinical Research
Translational Research
Human Single-Cell Multi-Omics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Single-Cell Multi-Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Single-Cell Multi-Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Single-Cell Multi-Omics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Human Single-Cell Multi-Omics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-Cell Proteomics
- Single-Cell Genomics
- Single-Cell Transcriptomics
Applications
- Synthetic Biology
- Clinical Research
- Translational Research
Companies covered
- 10x Genomics
- 1CellBio
- BGI Genomics
- Bio-Rad Laboratories
- Celsee
- Fluidigm Corporation
- Fluxion Biosciences
- MissionBio
- NanoString Technologies
- Takara Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Human Single-Cell Multi-Omics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single-Cell Proteomics
- 2.2.3 Single-Cell Genomics
- 2.2.4 Single-Cell Transcriptomics
- 2.3 Human Single-Cell Multi-Omics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Synthetic Biology
- 2.3.3 Clinical Research
- 2.3.4 Translational Research
- 2.4 Assumptions and Limitations
3 Human Single-Cell Multi-Omics Breakdown Data by Type
- 3.1 Global Human Single-Cell Multi-Omics Historic Market Size by Type (2021-2026)
- 3.2 Global Human Single-Cell Multi-Omics Forecasted Market Size by Type (2027-2032)
4 Human Single-Cell Multi-Omics Breakdown Data by Application
- 4.1 Global Human Single-Cell Multi-Omics Historic Market Size by Application (2021-2026)
- 4.2 Global Human Single-Cell Multi-Omics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Human Single-Cell Multi-Omics Market Perspective (2021-2032)
- 5.2 Global Human Single-Cell Multi-Omics Growth Trends by Region
- 5.2.1 Global Human Single-Cell Multi-Omics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Human Single-Cell Multi-Omics Historic Market Size by Region (2021-2026)
- 5.2.3 Human Single-Cell Multi-Omics Forecasted Market Size by Region (2027-2032)
- 5.3 Human Single-Cell Multi-Omics Market Dynamics
- 5.3.1 Human Single-Cell Multi-Omics Industry Trends
- 5.3.2 Human Single-Cell Multi-Omics Market Drivers
- 5.3.3 Human Single-Cell Multi-Omics Market Challenges
- 5.3.4 Human Single-Cell Multi-Omics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Human Single-Cell Multi-Omics Players by Revenue
- 6.1.1 Global Top Human Single-Cell Multi-Omics Players by Revenue (2021-2026)
- 6.1.2 Global Human Single-Cell Multi-Omics Revenue Market Share by Players (2021-2026)
- 6.2 Global Human Single-Cell Multi-Omics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Human Single-Cell Multi-Omics Head Office and Area Served
- 6.4 Global Human Single-Cell Multi-Omics Players, Product Type & Application
- 6.5 Global Human Single-Cell Multi-Omics Manufacturers Established Date
- 6.6 Global Human Single-Cell Multi-Omics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Human Single-Cell Multi-Omics Market Size (2021-2032)
- 7.2 North America Human Single-Cell Multi-Omics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 7.4 North America Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Human Single-Cell Multi-Omics Market Size (2021-2032)
- 8.2 Europe Human Single-Cell Multi-Omics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 8.4 Europe Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Human Single-Cell Multi-Omics Market Size (2021-2032)
- 9.2 Asia-Pacific Human Single-Cell Multi-Omics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Human Single-Cell Multi-Omics Market Size (2021-2032)
- 10.2 South America Human Single-Cell Multi-Omics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 10.4 South America Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Human Single-Cell Multi-Omics Market Size (2021-2032)
- 11.2 Middle East & Africa Human Single-Cell Multi-Omics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 10x Genomics
- 12.1.1 10x Genomics Company Information
- 12.1.2 10x Genomics Business Overview
- 12.1.3 10x Genomics Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.1.4 10x Genomics Human Single-Cell Multi-Omics Product Portfolio
- 12.1.5 10x Genomics Recent Developments
- 12.2 1CellBio
- 12.2.1 1CellBio Company Information
- 12.2.2 1CellBio Business Overview
- 12.2.3 1CellBio Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.2.4 1CellBio Human Single-Cell Multi-Omics Product Portfolio
- 12.2.5 1CellBio Recent Developments
- 12.3 BGI Genomics
- 12.3.1 BGI Genomics Company Information
- 12.3.2 BGI Genomics Business Overview
- 12.3.3 BGI Genomics Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.3.4 BGI Genomics Human Single-Cell Multi-Omics Product Portfolio
- 12.3.5 BGI Genomics Recent Developments
- 12.4 Bio-Rad Laboratories
- 12.4.1 Bio-Rad Laboratories Company Information
- 12.4.2 Bio-Rad Laboratories Business Overview
- 12.4.3 Bio-Rad Laboratories Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.4.4 Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio
- 12.4.5 Bio-Rad Laboratories Recent Developments
- 12.5 Celsee
- 12.5.1 Celsee Company Information
- 12.5.2 Celsee Business Overview
- 12.5.3 Celsee Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.5.4 Celsee Human Single-Cell Multi-Omics Product Portfolio
- 12.5.5 Celsee Recent Developments
- 12.6 Fluidigm Corporation
- 12.6.1 Fluidigm Corporation Company Information
- 12.6.2 Fluidigm Corporation Business Overview
- 12.6.3 Fluidigm Corporation Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.6.4 Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio
- 12.6.5 Fluidigm Corporation Recent Developments
- 12.7 Fluxion Biosciences
- 12.7.1 Fluxion Biosciences Company Information
- 12.7.2 Fluxion Biosciences Business Overview
- 12.7.3 Fluxion Biosciences Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.7.4 Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio
- 12.7.5 Fluxion Biosciences Recent Developments
- 12.8 MissionBio
- 12.8.1 MissionBio Company Information
- 12.8.2 MissionBio Business Overview
- 12.8.3 MissionBio Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.8.4 MissionBio Human Single-Cell Multi-Omics Product Portfolio
- 12.8.5 MissionBio Recent Developments
- 12.9 NanoString Technologies
- 12.9.1 NanoString Technologies Company Information
- 12.9.2 NanoString Technologies Business Overview
- 12.9.3 NanoString Technologies Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.9.4 NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio
- 12.9.5 NanoString Technologies Recent Developments
- 12.10 Takara Bio
- 12.10.1 Takara Bio Company Information
- 12.10.2 Takara Bio Business Overview
- 12.10.3 Takara Bio Revenue in Human Single-Cell Multi-Omics Business (2021-2026)
- 12.10.4 Takara Bio Human Single-Cell Multi-Omics Product Portfolio
- 12.10.5 Takara Bio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst